Global Gastrointestinal Over-The-Counter (OTC) Drugs Industry Outlook: Revenue and CAGR Projections to 2029

 Grab 20% Off With Code ONLINE20 On Global market Reports — Evaluate Global Trends, Market Risks, and Competitive Intelligence

 

 What Is the Growth Potential of the Gastrointestinal Over-The-Counter (OTC) Drugs Market Size Over 2025–2034?
 The gastrointestinal over-the-counter (otc) drugs market size has grown strongly in recent years. It will grow from $45.73 billion in 2024 to $49.59 billion in 2025 at a compound annual growth rate (CAGR) of 8.4%. The growth in the historic period can be attributed to the rising prevalence of gastrointestinal disorders, increasing consumer preference for self-medication, rise in availability of OTC proton pump inhibitors, increasing awareness of digestive health, and rise in geriatric population prone to GI issues.
 
 The gastrointestinal over-the-counter (otc) drugs market size is expected to see strong growth in the next few years. It will grow to $67.88 billion in 2029 at a compound annual growth rate (CAGR) of 8.2%. The growth in the forecast period can be attributed to growing demand for rapid symptom relief solutions, increasing penetration of e-commerce pharmacies, expanding availability of combination OTC therapies, rising focus on gut microbiome health, and increasing marketing and awareness campaigns by key players. Major trends in the forecast period include advancement in the formulation of fast-acting antacids, innovation in probiotic-based OTC products, integration of herbal ingredients in digestive remedies, advancement in packaging for dose accuracy and portability, and innovation in sustained-release gastrointestinal therapies.
 
 Get your free report sample today:
 https://www.thebusinessresearchcompany.com/sample.aspx?id=24547&type=smp
 
  What Are the Primary Factors Driving the Gastrointestinal Over-The-Counter (OTC) Drugs Market?
 The increasing prevalence of digestive disorders is expected to propel the growth of the gastrointestinal OTC drugs market going forward. Digestive disorders refer to a range of conditions that affect the gastrointestinal tract, including the stomach, intestines, and associated organs. The rise in digestive disorders is mainly due to higher intake of processed, low-fiber foods, which disrupt gut health and impair digestion. Gastrointestinal OTC drugs ease digestive disorder symptoms by reducing stomach acid, regulating bowel movements, and enhancing gut health. They provide fast, convenient relief from common issues like acidity, constipation, and indigestion. For instance, in December 2023, according to the IBD Registry Ltd., a UK-based non-profit organization, the number of individuals with inflammatory bowel disease (IBD) reached over 5,300, marking an increase of more than 3,000 members compared to 2022. Therefore, the increasing prevalence of digestive disorders is driving the growth of the gastrointestinal OTC drugs market.
 
 Which Segments Are Likely to Shape the Future Outlook of the Gastrointestinal Over-The-Counter (OTC) Drugs Market?
 The gastrointestinal over-the-counter (OTC) drugs market covered in this report is segmented — 
 
 1) By Product: Antacid, Laxatives, Anti-Diarrheal, Anti-Emetics, Other Products
 2) By Formulation: Tablets, Capsules, Liquids, Other Formulations
 3) By Indications: Heartburn, Diarrhoea, Constipation, Gastroesophageal Reflux Disease (GERD), Nausea, Vomiting, Motion Sickness, Other Indications
 4) By Distribution Channel: Direct Tender, Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels
 5) By End-Users: Hospitals, Clinics, Home Healthcare, Other End-Users
 
 Subsegments:
 1) By Antacid: Proton Pump Inhibitors (PPIs), H2-Receptor Antagonists, Calcium Carbonate, Magnesium Hydroxide, Sodium Bicarbonate, Combination Antacids
 2) By Laxatives: Bulk-Forming Laxatives, Stimulant Laxatives, Osmotic Laxatives, Stool Softeners, Lubricant Laxatives
 3) By Anti-Diarrheal: Loperamide, Bismuth Subsalicylate, Probiotics, Electrolyte Solutions
 4) By Anti-Emetics: Antihistamines, Bismuth Subsalicylate, Phosphorated Carbohydrate Solution, Ginger Supplements
 5) By Other Products: Digestive Enzymes, Antispasmodics, Simethicone, Herbal Remedies, Activated Charcoal
 
 Which Future-Ready Trends Are Expected to Influence the Gastrointestinal Over-The-Counter (OTC) Drugs Market?
 Major companies operating in the gastrointestinal OTC drugs market are focusing on developing advanced products, such as OTC proton pump inhibitors, to provide effective and long-lasting relief from acid-related disorders. Over-the-counter (OTC) proton pump inhibitors (PPIs) are a class of medications available without a prescription that reduce the production of stomach acid. They are commonly used to treat conditions such as frequent heartburn, acid reflux (GERD), and gastric ulcers. For instance, in March 2025, Eisai Co., Ltd., a Japan-based pharmaceutical company, received approval in Japan to switch its Pariet S (rabeprazole sodium 10 mg) from prescription (RX) to over-the-counter (OTC) status, making it the first OTC PPI in Japan containing the same active ingredient and dosage as the prescription product. Pariet S is indicated for stomach pain, heartburn, and bloating, offering 24-hour relief with a once-daily, easy-to-swallow tablet, and aims to address the growing need for effective gastric acid-related treatments due to lifestyle and demographic changes.
 
 Which Key Players Dominate the Gastrointestinal Over-The-Counter (OTC) Drugs Market Landscape?
 Major companies operating in the gastrointestinal over-the-counter (OTC) drugs market are Pfizer Inc., Procter & Gamble Co., Johnson & Johnson, Merck & Co. Inc., Bayer AG, Novartis AG, Sanofi S.A., AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., Reckitt Benckiser Group plc, Boehringer Ingelheim GmbH, Haleon plc, Sandoz AG, Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Perrigo Company plc, Dr. Reddy’s Laboratories Ltd. 
 
 Get the detailed gastrointestinal over-the-counter (otc) drugs market report today
 https://www.thebusinessresearchcompany.com/report/gastrointestinal-over-the-counter-otc-drugs-global-market-report
 
 Which Region Is Expected to Dominate the Gastrointestinal Over-The-Counter (OTC) Drugs Market During the Forecast Period?
 North America was the largest region in the gastrointestinal over-the-counter (OTC) drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastrointestinal over-the-counter (OTC) drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
 
 Contact Us:
 
 The Business Research Company: https://thebusinessresearchcompany.com/ 
 Americas +1 310–496–7795
 Asia +44 7882 955267 & +91 8897263534
 Europe +44 7882 955267 
 Email: info@tbrc.info 
 
 Follow Us On:
 
 LinkedIn: https://in.linkedin.com/company/the-business-research-company